Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    The Janus Corner

    Plants of the Genus Terminalia have High Antioxidant Content and Potent Antiproliferative Activity

    wadmin1By wadmin1April 1, 2021Updated:August 5, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Mitchell Henry Wright
    Leviathan Biosciences, Brisbane, Queensland, AUSTRALIA.

    Pharmacognosy Communications,2021,11,2,142.
    DOI:10.5530/pc.2021.2.26
    Published: April 2021
    Type: The Janus Corner

    ABSTRACT

    The genus Terminalia comprise over 250 species and are well-documented for their use in traditional (Ayurveda) medicines.1 Investigations into the medicinal potential of these plants has revealed that they not only contain numerous anti-inflammatory and antibacterial compounds2-7 but can prevent the development of cancers, as well as the induction of apoptosis of cancerous cells.8 Recently, an article that was written by Cock and Cheesman8 that summarises the available research on Terminalia spp. from a pharmacognostic standpoint. Focusing on the phytochemical profiles of these plants, as well as their therapeutic properties with respect to cancer proliferation, the review is a well-written paper and is a great resource for researchers and casual readers alike. The authors look at the applications to cancers and other conditions, the phytochemical profile (and antioxidant contents) of plants within the genus, including T. ferdinandiana, whose fruit are one of the richest natural sources of ascorbic acid. The chapter highlights the relationship between oxidative stress and cancer and explains the different biological compounds contained within Terminalia spp. that could contribute to preventing the formation of cancers. Finally, the review summarises the key points of the chapter, effectively collating the chapter through a series of dot points. Overall, this review is an informative read and offers a wonderful tool for both scientists and recreational plant enthusiasts. Read more…

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up